Release of interleukin-1 receptor antagonist by combining a leukocyte adsorption carrier with ulinastatin

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 4, 2010, Pages 386-391

  Nishise, Shoichi ^a   Takeda, Yuji ^b   Fujishima, Shoichiro ^a   Orii, Tomohiko ^a   Sato, Takeshi ^a   Sasaki, Yu ^a   Nishise, Yuko ^a   Takeda, Hiroaki ^a   Kawata, Sumio ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Adsorption; Granulocytes; Interleukin 1 receptor antagonist; Ulcerative colitis; Ulinastatin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CELLULOSE ACETATE; GABEXATE MESILATE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; ULINASTATIN; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; CELLULOSE; FLAVONOID; GABEXATE; GLYCOPROTEIN; INTERLEUKIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRYPSIN INHIBITOR;

APHERESIS; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; GRANULOCYTE; GRANULOCYTE MONOCYTE ADSORPTIVE APHERESIS; HUMAN; PRIORITY JOURNAL; ADSORPTION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COLITIS, ULCERATIVE; COMPARATIVE STUDY; DOSE RESPONSE; IN VITRO STUDY; METABOLISM; MONOCYTE; PROCEDURES;

ADSORPTION; BLOOD COMPONENT REMOVAL; CELLULOSE; COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GABEXATE; GLYCOPROTEINS; GRANULOCYTES; HUMANS; IN VITRO TECHNIQUES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; RECEPTORS, INTERLEUKIN-1; TRYPSIN INHIBITORS;

EID: 77955071576     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00820.x     Document Type: Article

References (24)

1. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998 22 : 382 389.
2. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995 16 : 21 6.
3. Kashiwagi N, Sugimura K, Koiwai H et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002 47 : 1334 1341.
4. Yamamoto T, Saniabadi AR, Umegae S, Matsumoto K. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings. Inflamm Bowel Dis 2006 12 : 719 726.
5. Hanai H, Watanabe F, Takeuchi K et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003 1 : 28 35.
6. Takeda Y, Hiraishi K, Takeda H et al. Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-α or interleukin-1β in human peripheral blood. Inflamm Res 2003 52 : 287 290.
7. Hanai H, Iida T, Yamada M et al. Effects of Adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis. World J Gastroenterol 2006 12 : 3393 3399.
8. Nishise S, Takeda Y, Takeda H, Ishihama K, Fukui T, Kawata S. Complement activation is involved in biological responses to leukocyte adsorptive apheresis. Dig Dis Sci 2006 51 : 934 941.
9. Nakamura K, Yamaguchi K, Motoya Y, Hashimoto S, Ishibashi M. Inhibitory effects of various protease inhibitors on complement-mediated hemolysis. Jpn J Hosp Pharm 1988 14 : 339 346.
10. Kobayashi H, Gotoh J, Kanayama N, Hirashima Y, Terao T, Sugino D. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region in urinary trypsin inhibition. Cancer Res 1995 55 : 1847 1852.
11. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock 2001 15 : 101 105.
12. Sato Y, Ishikawa S, Otaki A et al. Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury. Jpn J Thorac Cardiovasc Surg 2000 48 : 428 434.
13. Bingyang J, Jinping L, Mingzheng L, Guyan W, Zhengyi F. Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response. J Cardiovasc Surg (Torino) 2007 48 : 497 503.
14. Inoue K, Takano H, Shimada A et al. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 2005 67 : 673 680. (Pubitemid 40365315)
15. Ito H, Maruyama S, Fukushima K et al. Rectal mucosal blood flow in ulcerative colitis. J Kyorin Med Soc 1994 25 : 423 425.
16. Nishida Y, Murase K, Furusu H et al. Response to urinary trypsin inhibitor therapy in ulcerative colitis is associated with a decrease in mast cell count in the colonic mucosa. Acta Med Nagasaki 1999 44 : 39 43.
17. Sakimura K, Omori T, Iwashita E et al. Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci 2006 51 : 1525 1531.
18. Takeda Y, Shiobara N, Saniabadi AR, Adachi M, Hiraishi K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin. Inflamm Res 2004 53 : 277 283.
19. Nishise S, Takeda Y, Nishise Y et al. Biological effect of anaphylatoxin C5a on the generation of anti-inflammatory substances in leukocyte adsorption. Ther Apher Dial 2009 13 : 509 514.
20. Rainger GE, Rowley AF, Nash GB. Adhesion-dependent release of elastase from human neutrophils in a novel, flow-based model: specificity of different chemotactic agents. Blood 1998 92 : 4819 4827.
21. Riedemann NC, Guo RF, Hollmann TJ et al. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 2004 18 : 370 372.
22. Hazan-Halevy I, Seger R, Levy R. The requirement of both extracellular regulated kinase and p38 mitogen-activated protein kinase for stimulation of cytosolic phospholipase A(2) activity by either FcgammaRIIA or FcgammaRIIIB in human neutrophils. A possible role for Pyk2 but not for the Grb2-Sos-Shc complex. J Biol Chem 2000 275 : 12416 12423.
23. Molor-Erdene P, Okajima K, Isobe H et al. Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo. Thromb Haemost 2005 94 : 136 145.
24. Kuroki M, O'Flaherty JT. Differential effects of a mitogen-activated protein kinase kinase inhibitor on human neutrophil responses to chemotactic factors. Biochem Biophys Res Commun 1997 232 : 474 477.